InvestorsHub Logo
Followers 8
Posts 628
Boards Moderated 0
Alias Born 05/26/2021

Re: JediMozart post# 12209

Thursday, 04/28/2022 2:34:04 PM

Thursday, April 28, 2022 2:34:04 PM

Post# of 13742
Correction on email address
QNTA ir@medoliferx.com
i corrected it below as well (I can’t seem to edit my original posts from my phone so I’m reposting with the corrected qnta contact email address)

FYI They have improved their response time to emails .. i suggest, to put one’s mind at ease, email them at:

ir@medoliferx.com

For anyone with questions about QNTA may I suggest contacting them directly at

ir@medoliferx.com

Put all your concerns, questions, etc in an email and ask for information at

ir@medoliferx.com

ALSO worth noting .. historically, Dr. Mikaelian and the QNTA folks have been great at responding to asked questions when they have a conference call

It is true that companies cannot always answer “all” questions… but most of the time enough allowable / shareable information can be disseminated to set investors minds at ease …
I suggest contacting them INSTEAD of blanketly and wildly speculating… ask the folks at qnta directly

As for the company moving forward my stance hasn’t wavered … like the little engine that could they are persevering .. 2020 brought with it Many obstacles … which to qnta credit they’ve kept the doors open and are striving to keep their goals in sight … ultimately goal to bring the escozine and their other science technology to the masses .. their continued data gathered thusly continues to show it’s products are effective ..

Again, I encourage folks to reach out
ir@medoliferx.com

QNTA MedolifeRx AELIA Escozine

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.